PredictImmune Gains CE-IVD Mark for IBD Test

Dec 11, 2018

|

NEW YORK (GenomeWeb) – PredictImmune has obtained a CE-IVD mark for its debut test for inflammatory bowel disease, the company said today.

By achieving certification for the test, called PredictSure IBD, the Cambridge, UK-based firm can sell it for clinical use across Europe and other geographies that recognize the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lander Nominated for Science Advisor

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

What's It Called?

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

Twin COVID-19 Studies

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

PNAS Papers on Positive Epistasis in Cystic Fibrosis, Tiger Rattlesnake Genome, More

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.

Featured White Papers

Automated Affinity Purification of Immunoglobulins (IgGs) Using INtip Dispersive Solid-Phase Extraction Technology

Increase Your Sample Screening and Genotyping Assay Throughput with the VOYAGER Adjustable Tip Spacing Pipette

Setting up a 384-well qRT-PCR Assay for the ViiA 7 Using VIAFLO and VOYAGER Electronic Pipettes

Automated Nucleic Acid Extraction and RT-PCR Setups for SARS-CoV-2 Testing

Jan

26

Featured Webinar

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.

Jan

28

Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources.

Feb

11

Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb

17

Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Menu

PredictImmune Gains CE-IVD Mark for IBD Test

To read the full story....

Breaking News

Devyser Receives €750K Grant to Build Sequencing Assay for Early Detection of Transplant Rejection

Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

OncoHost Raises $8 Million in Series B Funding Round

Top Five Articles on GenomeWeb Last Week: JP Morgan Healthcare, Illumina, Ancestry, and More

ABO Histo-Blood Groups Influence Makeup of Gut Microbiome, New Study Finds

Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

The Scan

Lander Nominated for Science Advisor

What's It Called?

Twin COVID-19 Studies

PNAS Papers on Positive Epistasis in Cystic Fibrosis, Tiger Rattlesnake Genome, More

Featured White Papers

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

What's Popular?

Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Lucira Health Files for $115M IPO

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Sponsorships